Publications by authors named "Thomas F Scott"

Claim this Profile
E
Early treatment responses to peginterferon beta-1a are associated with longer-term clinical outcomes in patients with relapsing-remitting multiple sclerosis: Subgroup analyses of ADVANCE and ATTAIN.
Scott D Newsome, Thomas F Scott, Douglas L Arnold, Arman Altincatal, Maria L Naylor

Mult Scler Relat Disord· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurosarcoidosis mimicry of MS: Clues from cases with CNS tissue diagnosis.
Thomas F Scott

J Neurol Sci· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world prognosis in MS: does early versus late diagnosis matter?
Jikku Zachariah, Timothy Quezada, Troy Desai, Rebecca E Schorr, Thomas F Scott

Neurol Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-Reported Barriers to Exercise and Factors Impacting Participation in Exercise in Patients with Parkinson's Disease.
Prarthana Prakash, Thomas F Scott, Susan M Baser, Timothy Leichliter, Carol J Schramke

Mov Disord Clin Pract· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Word cloud for hospitalization admission diagnoses in patients with multiple sclerosis.
Rebecca L Vislay-Wade, Thomas F Scott

Mult Scler Relat Disord· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matching comparisons of therapeutic efficacy suggest better clinical outcomes for patients treated with peginterferon beta-1a than with glatiramer acetate.
Thomas F Scott, Ray Su, Kuangnan Xiong, Arman Altincatal, Carmen Castrillo-Viguera

Ther Adv Neurol Disord· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large hemispheric lesions in autoimmune encephalitis associated with anti-GAD 65 antibodies.
Bahareh Sianati, Sandeep S Rana, Murat Sari, Jody Leonardo, Thomas F Scott

Mult Scler Relat Disord· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of multiple sclerosis relapses on worsening over the long term; insights in the treatment era.
Thomas F Scott, Nicholas Bertha

J Neurol Sci· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is baseline routine renal ultrasound indicated for all MS patients?
Igor B Títoff, Victoria Titoff, Thomas F Scott

Postgrad Med J· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in a Modern Cohort of Treated Patients with Multiple Sclerosis from Diagnosis Up to 15 Years.
Thomas F Scott, Troy Desai, Chris Hackett, Edward J Gettings, Teresa Hentosz

Int J MS Care· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple sclerosis relapses contribute to long-term disability.
Thomas F Scott, Daniel Diehl, Wisam Elmalik, Edward J Gettings, Chris Hackett

Acta Neurol Scand· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of peginterferon beta-1a in multiple sclerosis: results from the ADVANCE extension study, ATTAIN.
Scott D Newsome, Thomas F Scott, Douglas L Arnold, Gereon Nelles, Serena Hung

Ther Adv Neurol Disord· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient IgG deficiency with lesions in brain and spinal cord: a mimicker of common variable immunodeficiency syndrome.
Konark Malhotra, Ramnath Santosh Ramanathan, Thomas F Scott

Acta Neurol Belg· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A man in his 40s with altered mental status, ataxia and unilateral weakness.
Konark Malhotra, Monica Khunger, Cunfeng Pu, Thomas F Scott

Neuropathology· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the impact of relapses in the overall course of MS; refinement of the 2 stage natural history model.
Thomas F Scott

J Neuroimmunol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in relapse recovery with peginterferon beta-1a in patients with multiple sclerosis.
Thomas F Scott, Bernd C Kieseier, Scott D Newsome, Douglas L Arnold, Xiaojun You

Mult Scler J Exp Transl Clin· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Neuropathic Pain and Functional Limitations Associated With Multiple Sclerosis Using an MRI-Compatible Spinal Cord Stimulator: A Case Report With Two Year Follow-Up and Literature Review.
David A Provenzano, Joseph R Williams, Gaye Jarzabek, Leonard A DeRiggi, Thomas F Scott

Neuromodulation· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific clinical phenotypes in relapsing multiple sclerosis: The impact of relapses on long-term outcomes.
Thomas F Scott, Edward J Gettings, Christopher T Hackett, Carol J Schramke

Mult Scler Relat Disord· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple sclerosis relapse phenotype is an important, neglected, determinant of disease outcome - YES.
Thomas F Scott

Mult Scler· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma.
Edward J Gettings, Christopher T Hackett, Thomas F Scott

Mult Scler· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapsing multiple sclerosis patients treated with disease modifying therapy exhibit highly variable disease progression: a predictive model.
Thomas F Scott, Christopher T Hackett, Matthew R Quigley, Carol J Schramke

Clin Neurol Neurosurg· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spinal cord neurosarcoidosis.
Mimi Sohn, Daniel A Culver, Marc A Judson, Thomas F Scott, Jinny Tavee

Am J Med Sci· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggressive relapsing multiple sclerosis characterized by rapid disability progression.
Thomas F Scott, Genevieve Laforet, Xiaojun You

Mult Scler Relat Disord· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are we studying MS relapses in the right way?
Thomas F Scott

Mult Scler Relat Disord· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolated neurosarcoidosis: case series in 2 sarcoidosis centers.
Kenkichi Nozaki, Thomas F Scott, Mimi Sohn, Marc A Judson

Neurologist· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis